検索結果 1 - 9 結果 / 9 検索語 'Maria D Odero', 処理時間: 0.05秒 結果の絞り込み
  1. 1
    The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias

    The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias 著者: Raffaella Pippa, Maria D. Odero

    出版事項 2020-02-01
    全文の入手
    論文
  2. 2
    Correction: 3′UTR-Mediated Gene Silencing of the Mixed Lineage Leukemia (MLL) Gene.

    Correction: 3′UTR-Mediated Gene Silencing of the Mixed Lineage Leukemia (MLL) Gene. 著者: Maria Gomez-Benito, Fabricio Loayza-Puch, Joachim A. F. Oude Vrielink, Maria D. Odero, Reuven Agami

    出版事項 2011-01-01
    全文の入手
    論文
  3. 3
    Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells

    Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells 著者: Ion Cristóbal, Cristina Cirauqui, Remedios Castello-Cros, Laura Garcia-Orti, María J. Calasanz, María D. Odero

    出版事項 2013-09-01
    全文の入手
    論文
  4. 4
    3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene.

    3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) gene. 著者: Maria Gomez-Benito, Fabricio Loayza-Puch, Joachim A F Oude Vrielink, Maria D Odero, Reuven Agami

    出版事項 2011-01-01
    全文の入手
    論文
  5. 5
    Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.

    Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia. 著者: Laura García-Ortí, Ion Cristóbal, Cristina Cirauqui, Elisabet Guruceaga, Nerea Marcotegui, María J Calasanz, Remedios Castello-Cros, María D Odero

    出版事項 2012-01-01
    全文の入手
    論文
  6. 6
    Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia

    Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia 著者: Ion Cristóbal, Laura Garcia-Orti, Cristina Cirauqui, Xabier Cortes-Lavaud, María A. García-Sánchez, María J. Calasanz, María D. Odero

    出版事項 2012-04-01
    全文の入手
    論文
  7. 7
    In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia

    In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia 著者: Kim De Keersmaecker, Idoya Lahortiga, Nicole Mentens, Cedric Folens, Leander Van Neste, Sofie Bekaert, Peter Vandenberghe, Maria D. Odero, Peter Marynen, Jan Cools

    出版事項 2008-04-01
    全文の入手
    論文
  8. 8
    CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

    CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia 著者: Eva Barragán, María Carmen Chillón, Remedios Castelló-Cros, Nerea Marcotegui, María Isabel Prieto, Montserrat Hoyos, Raffaella Pippa, Marta Llop, Amaia Etxabe, José Cervera, Gabriela Rodríguez, Ismael Buño, José Rifón, Jorge Sierra, Marcos González, María J. Calasanz, Miguel A. Sanz, María D. Odero

    出版事項 2015-05-01
    全文の入手
    論文
  9. 9
    Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

    Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia 著者: Iria Vázquez, Miren Maicas, José Cervera, Xabier Agirre, Oskar Marin-Béjar, Nerea Marcotegui, Carmen Vicente, Idoya Lahortiga, Maria Gomez-Benito, Claudia Carranza, Ana Valencia, Salut Brunet, Eva Lumbreras, Felipe Prosper, María T. Gómez-Casares, Jesús M. Hernández-Rivas, María J. Calasanz, Miguel A. Sanz, Jorge Sierra, María D. Odero

    出版事項 2011-10-01
    全文の入手
    論文

検索ツール: